Instructions / Instruction for use: Fluoxetine LannacherI want this, give me price
Dosage form: capsules
Active substance: Fluoxetine*
The nosological classification (ICD-10)
F32 Depressive episode: Adynamic subdepression; Astheno-adynamic subdepressive states; Asthenoadressive disorder; Astheno-depressive disorder; Asthenodepressive state; Astheno-depressive state; Major Depressive Disorder; Vyaloapatichesky depression with retardation; Double Depression; Depressive pseudodement; Depressive illness; Depressive mood disorder; Depressive disorder; Depressive mood disorder; Depressive state; Depressive disorders; Depressive syndrome; Depressive syndrome larviated; Depressive syndrome in psychoses; Depressed masks; Depression; Depression Depletion; Depression with the phenomena of inhibition within the framework of cyclothymia; Depression is smiling; Involutional depression; Involutionary melancholy; Involutional depression; Manic-depressive disorder; Masked Depression; Melancholic Attack; Neurotic depression; Neurotic depression; Shallow Depression; Organic depression; Organic depressive syndrome; Simple depression; Simple melancholic syndrome; Psychogenic depression; Reactive depression; Reactive depression with moderate psychopathological symptoms; Reactive depressive states; Reactive depression; Recurrent depression; Seasonal depressive syndrome; Severostatic depression; Senile Depression; Symptomatic Depression; Somatogenic depression; Cyclotymic depression; Exogenous depression; Endogenous depression; Endogenous Depressive Conditions; Endogenous Depression; Endogenous depressive syndrome
F42 Obsessive-compulsive disorder: Obsessive-compulsive syndrome; Obsessive compulsive states; Obsessive-compulsive syndrome; The Obsession Syndrome; The obsession neurosis; Obsessive-compulsive neurosis; Obsessions
F50.2 Nervous Bulimia: Bulimic Neurosis; Bulimia; Wolf hunger; Kinorexia
Composition and release form
Capsules - 1 caps.
fluoxetine hydrochloride 20 mg
in a blister of 10 pcs .; in the box 2 blisters.
Pharmacological action - antidepressant.
Selective blocker of serotonin reuptake in synapses of CNS neurons. It has a small effect on cholinergic, adrenergic and histamine receptors. Helps improve mood, eliminate feelings of fear, emotional tension, dysphoria. Practically does not have a sedative effect. A persistent clinical effect, as a rule, develops after 2-3 weeks of continuous intake of the drug.
Well absorbed in the digestive tract, regardless of food intake. Bioavailability of 60-80%. Cmax is achieved in 4-8 hours. Binding to plasma proteins is about 90%. Metabolised in the liver with the formation of a pharmacologically active metabolite of norfluoxetine. T1 / 2 active ingredient - 2-3 days, norfluoxetine - 7-9 days. Excreted by the kidneys (95% in the form of metabolites).
Indications Fluoxetine Lannacher
Depression of various genesis, bulimia nervosa, obsessive-compulsive disorder (obsessive states).
Dosing and Administration
Inside. A stable clinical effect is achieved after 2-3 weeks of treatment, supportive therapy can last up to 6 months.
Depression: 20 mg once a day in the morning. If necessary, after 3-4 weeks, the dose may be increased to 20 mg twice a day (morning and evening). The maximum daily dose is 80 mg 1-2 times a day.
Bulimic neurosis: up to 60 mg / day.
Obsessive-compulsive disorder: 20-60 mg / day.
Storage conditions for Fluoxetine Lannacher
In a dry, the dark place at a temperature of no higher than 25 ° C.
Keep out of the reach of children.
Shelf life of Fluoxetine Lannacher
Do not use after the expiry date printed on the package.